Cuthbertson, Daniel J.

Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle

Cuthbertson, D., Smith, K., Babraj, J., Leese, G., Waddell, T., Atherton, P., Wackerhage, H., Taylor, P. M., & Rennie, M. J. (2005) · The FASEB Journal

Muscle metabolism and nutritionNutrition and Health in Aging

Cited by 1,211

SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications

Brown, E., Heerspink, H. J. L., Cuthbertson, D. J., & Wilding, J. P. H. (2021) · The Lancet

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 581

Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy

Iqbal, Z., Azmi, S., Yadav, R., Ferdousi, M., Kumar, M., Cuthbertson, D. J., Lim, J., Malik, R. A., & Alam, U. (2018) · Clinical Therapeutics

Pain Mechanisms and TreatmentsPeripheral Neuropathies and Disorders

Cited by 487

Reduced physical activity in young and older adults: Metabolic and musculoskeletal implications

Bowden Davies, K. A., Pickles, S., Sprung, V. S., Kemp, G. J., Alam, U., Moore, D. R., Tahrani, A. A., & Cuthbertson, D. J. (2019) · Therapeutic Advances in Endocrinology and Metabolism

Physical Activity and HealthCardiovascular and exercise physiology

Cited by 278

Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients

Daniel, E., Aylwin, S., Mustafa, O., Ball, S., Munir, A., Boelaert, K., Chortis, V., Cuthbertson, D. J., Daousi, C., Rajeev, S. P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 231

Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Cuthbertson, D. J., Irwin, A., Gardner, C. J., Daousi, C., Purewal, T., Furlong, N., Goenka, N., Thomas, E. L., Adams, V. L., Pushpakom, S. P., et al. (2012) · PLoS ONE

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 226

Anabolic signaling and protein synthesis in human skeletal muscle after dynamic shortening or lengthening exercise

Cuthbertson, D. J., Babraj, J., Smith, K., Wilkes, E., Fedele, M. J., Esser, K., & Rennie, M. (2006) · American Journal of Physiology-Endocrinology and Metabolism

Muscle metabolism and nutritionMuscle Physiology and Disorders

Cited by 166

Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease

Cuthbertson, D. J., Shojaee-Moradie, F., Sprung, V. S., Jones, H., Pugh, C. J. A., Richardson, P., Kemp, G. J., Barrett, M., Jackson, N. C., Thomas, E. L., et al. (2016) · Clinical Science

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 138

Short-term decreased physical activity with increased sedentary behaviour causes metabolic derangements and altered body composition: effects in individuals with and without a first-degree relative with type 2 diabetes

Bowden Davies, K. A., Sprung, V. S., Norman, J. A., Thompson, A., Mitchell, K. L., Halford, J. C. G., Harrold, J. A., Wilding, J. P. H., Kemp, G. J., & Cuthbertson, D. J. (2018) · Diabetologia

Physical Activity and HealthAdipokines, Inflammation, and Metabolic Diseases

Cited by 138

Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review

Williams, S. M., Eleftheriadou, A., Alam, U., Cuthbertson, D. J., & Wilding, J. P. H. (2019) · Diabetes Therapy

Heart Rate Variability and Autonomic ControlDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 128

Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD

Shojaee-Moradie, F., Cuthbertson, D. J., Barrett, M., Jackson, N. C., Herring, R., Thomas, E. L., Bell, J., Kemp, G. J., Wright, J., & Umpleby, A. M. (2016) · The Journal of Clinical Endocrinology & Metabolism

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 116

Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease

Pugh, C. J. A., Sprung, V. S., Kemp, G. J., Richardson, P., Shojaee-Moradie, F., Umpleby, A. M., Green, D. J., Cable, N. T., Jones, H., & Cuthbertson, D. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology

Liver Disease Diagnosis and TreatmentCardiovascular and exercise physiology

Cited by 116

American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease

Stine, J. G., Long, M. T., Corey, K. E., Sallis, R. E., Allen, A. M., Armstrong, M. J., Conroy, D. E., Cuthbertson, D. J., Duarte-Rojo, A., Hallsworth, K., et al. (2023) · Hepatology Communications

Liver Disease Diagnosis and TreatmentPhysical Activity and Health

Cited by 89

Dynapenic obesity and the risk of incident Type 2 diabetes: the english longitudinal study of ageing

Cuthbertson, D. J., Bell, J. A., Ng, S. Y., Kemp, G. J., Kivimaki, M., & Hamer, M. (2016) · Diabetic Medicine

Nutrition and Health in AgingDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 86

The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)

Thondam, S. K., Cuthbertson, D. J., & Wilding, J. P. H. (2020) · Peptides

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Cited by 77

Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response

Thondam, S. K., Daousi, C., Wilding, J. P. H., Holst, J. J., Ameen, G. I., Yang, C., Whitmore, C., Mora, S., & Cuthbertson, D. J. (2017) · American Journal of Physiology-Endocrinology and Metabolism

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 71

GH deficiency after traumatic brain injury: Improvement in quality of life with GH therapy: Analysis of the KIMS database

Gardner, C. J., Mattsson, A. F., Daousi, C., Korbonits, M., Koltowska-Haggstrom, M., & Cuthbertson, D. J. (2015) · European Journal of Endocrinology

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 65

Impact of bariatric surgery on physical functioning in obese adults

Steele, T., Cuthbertson, D. J., & Wilding, J. P. H. (2015) · Obesity Reviews

Bariatric Surgery and OutcomesBody Contouring and Surgery

Cited by 62

Obesity pharmacotherapy in older adults: a narrative review of evidence

Henney, A. E., Wilding, J. P. H., Alam, U., & Cuthbertson, D. J. (2025) · International Journal of Obesity

Pharmacology and Obesity TreatmentNutrition and Health in Aging

Cited by 51

Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study

Anson, M., Henney, A. E., Broadwell, N., Zhao, S. S., Ibarburu, G. H., Lip, G. Y. H., Wilding, J. P. H., Cuthbertson, D. J., & Alam, U. (2024) · eClinicalMedicine

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 44

Exercise improves surrogate measures of liver histological response in metabolic dysfunction‐associated steatotic liver disease

Cuthbertson, D. J., Keating, S. E., Pugh, C. J. A., Owen, P. J., Kemp, G. J., Umpleby, M., Geyer, N. G., Chinchilli, V. M., & Stine, J. G. (2024) · Liver International

Liver Disease Diagnosis and TreatmentPhysical Activity and Health

Cited by 38

Effects of 6 months glucagon‐like peptide‐1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients

Hopkins, N. D., Cuthbertson, D. J., Kemp, G. J., Pugh, C., Green, D. J., Cable, N. T., & Jones, H. (2013) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementCardiovascular Health and Disease Prevention

Cited by 31

Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes

Hydes, T. J., Summers, N., Brown, E., Alam, U., Thomaides‐Brears, H., Wilding, J. P. H., & Cuthbertson, D. J. (2020) · Diabetic Medicine

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 21